Cargando…
Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report
An 80-year-old Japanese male patient with Behçet’s disease presented with a seven-day history of fever, cough, and progressive shortness of breath after receiving a second dose of the BNT16B2b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). The initial diagnosis was community-acquired pneumonia, and antib...
Autores principales: | Kojima, Yuichi, Takeyabu, Kimihiro, Satoh, Miki, Konno, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of British Infection Association.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533633/ https://www.ncbi.nlm.nih.gov/pubmed/36212609 http://dx.doi.org/10.1016/j.clinpr.2022.100204 |
Ejemplares similares
-
Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases
por: Ahmed, Sirwan Khalid
Publicado: (2022) -
Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
por: Rodríguez-Jiménez, Pedro, et al.
Publicado: (2021) -
Humoral immune response in healthcare workers after two doses of a BNT162b2 mRNA vaccine in Yucatan, Mexico
por: Figueroa‐Hurtado, Esperanza, et al.
Publicado: (2022) -
A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination
por: King, Eleanor R., et al.
Publicado: (2021) -
Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
por: Karatas, Elif, et al.
Publicado: (2022)